CHM 0.00% 1.8¢ chimeric therapeutics limited

valuation thoughts, page-231

  1. 1,273 Posts.
    lightbulb Created with Sketch. 739
    You just gained a better understanding of these types of listed Oppies than majority of investors. Well Done.

    Time will tell if swapping half my heads into 3x number of oppies is a good investment or not, but I believe so.

    Share Price needs to get to 39c (based on my circumstances) or circa 93 million market cap before my overall $ figure (including paying the CHMO 25.5 exercise price) is better off, but for every 1c thereafter the gains are 3x larger vs simple holding heads.

    Best part is also the ability to simply sell these listed options on market prior to expiry date, in which case percentage returns are much larger due to this leverage and CGT discount also applies if you hold CHMO for longer than 12 months, but once you pay to convert into Fully Paid Ordninary Shares the CGT clock resets.

    Whack some figures into excel to see what works for you, it gets silly at SP north of $1, which is still only a $500m AUD fully diluted market cap for a company with 3 platforms and multple cancer targets.

    Lots ot like here.






 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $15.76M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $9.531K 515.5K

Buyers (Bids)

No. Vol. Price($)
15 1853294 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 100000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.